Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 12/20 | 1.00 |
| ▸ | GBA1 | P04062 | 9/20 | 0.80 |
| ▸ | NPC1 | O15118 | 8/20 | 0.80 |
| ▸ | MEN1 | O00255 | 5/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.80 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.77 |
| ▸ | MAPT | P10636 | 4/20 | 0.77 |
| ▸ | TP53 | P04637 | 3/20 | 0.77 |
| ▸ | POLB | P06746 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | GRM5 | P41594 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1142765 | 0.89 | RAB9A (1.00) | RAB9AGBA1NPC1MEN1KMT2A | |
| SCHEMBL31725239 | 0.88 | RAB9A (0.78) | RAB9AGBA1NPC1MEN1KMT2A | |
| SCHEMBL3119185 | 0.88 | RAB9A (0.78) | RAB9AGBA1NPC1MEN1KMT2A | |
| SCHEMBL27573763 | 0.87 | RAB9A (0.75) | RAB9AGBA1NPC1MEN1KMT2A | |
| SCHEMBL49953 | 0.86 | RAB9A (0.75) | RAB9AGBA1NPC1MEN1KMT2A | |
| SCHEMBL29704545 | 0.86 | RAB9A (0.75) | RAB9AGBA1NPC1MEN1KMT2A | |
| SCHEMBL29351108 | 0.86 | RAB9A (0.74) | RAB9AGBA1NPC1MEN1KMT2A | |
| SCHEMBL5631286 | 0.84 | RAB9A (0.72) | RAB9AGBA1NPC1MEN1KMT2A | |
| SCHEMBL30509648 | 0.84 | RAB9A (0.72) | RAB9AGBA1NPC1MEN1KMT2A | |
| SCHEMBL5034141 | 0.84 | RAB9A (0.72) | RAB9AGBA1NPC1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023176554-A1 | COGNITIVE-FUNCTION-IMPROVING AGENT | 国立大学法人東北大学 | 2023-09-21 | — | — | WO | disclosed |
| EP-2546235-B1 | PROCESS FOR PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS | NIPPON SODA CO (JP) | 2019-05-22 | — | — | EP | disclosed |
| US-8653269-B2 | Process for preparation of t-butoxycarbonylamine compounds | NIPPON SODA CO., LTD. (JP) | 2014-02-18 | — | — | US | disclosed |
| EP-2546235-A1 | PROCESS FOR PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS | Nippon Soda Co., Ltd. (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-20130005981-A1 | PROCESS FOR PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS | NIPPON SODA CO., LTD. (JP) | 2013-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005981-A1 | PROCESS FOR PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS | BPGM, TST, BET1 | RAB9A 3206/4885GBA1 1253/4885NPC1 2994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.